Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence
Author:
Funder
Cancer Epidemiology Unit
MRC
Publisher
Elsevier BV
Subject
General Medicine
Reference21 articles.
1. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancer;Lancet,1997
2. Menopausal hormone use and ovarian cancer risk: individual participant meta-analysis of 52 epidemiological studies;Beral;Lancet,2015
3. Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies;Lancet,1996
4. Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50 302 women with breast cancer and 96 973 women without the disease;Lancet,2002
5. Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies;Lancet Oncol,2012
Cited by 446 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Progestins and breast cancer hallmarks: The role of the ERK1/2 and JNK pathways in estrogen receptor positive breast cancer cells;The Journal of Steroid Biochemistry and Molecular Biology;2024-03
2. A comprehensive review of small molecules targeting PI3K pathway: Exploring the structural development for the treatment of breast cancer;Bioorganic Chemistry;2024-02
3. Effectiveness and safety of menopause treatments: pitfalls of available evidence and future research need;Climacteric;2024-01-26
4. Efficacy of plant‐derived dietary supplements in improving overall menopausal symptoms in women: An updated systematic review and meta‐analysis;Phytotherapy Research;2024-01-08
5. Counseling in menopausal women: How to address the benefits and risks of menopause hormone therapy. A FIGO position paper;International Journal of Gynecology & Obstetrics;2024-01-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3